CVI Holdings’s RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 RXIIW Stock Holding History

CVI Holdings’s Portfolio RXIIW Stock Details RXIIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-221,015	Closed	-$77K	–	58
2018 Q3	$77K	Sell	221,015 -41	-0%	-$19	0.13%	28
2018 Q2	$55K	Sell	221,056 -630	-0.3%	-$273	0.07%	37
2018 Q1	$100K	Buy	+221,686	New	+$144K	0.14%	31

CVI Holdings's RXIIW Position: Q4 2018 in Review

CVI Holdings sold out of RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 (RXIIW) in Q4 2018, closing a stake of 221,015 shares — an estimated $77K sold.

CVI Holdings first reported a position in RXIIW in Q1 2018 and held it in 3 quarters. The position peaked at $100K in Q1 2018. 0 funds tracked by Wall St. Rank hold RXIIW as of Q4 2018.

CVI Holdings reported no remaining RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 position as of Q4 2018 after selling out during the quarter.
CVI Holdings sold 221,015 RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 shares in Q4 2018, an estimated $77K.
CVI Holdings first reported a position in RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 in Q1 2018 and held it in 3 quarters.
CVI Holdings's RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 position peaked at $100K in Q1 2018.
0 funds tracked by Wall St. Rank held RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 as of Q4 2018.

Based on CVI Holdings's 13F filing for Q4 2018, filed 14 Feb 2019.